BNP Paribas Financial Markets’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.7B Buy
21,155,872
+4,568,518
+28% +$570M 1.78% 7
2025
Q4
$2.02B Buy
16,587,354
+10,622,553
+178% +$1.22B 1.28% 15
2025
Q3
$598M Sell
5,964,801
-1,645,780
-22% -$148M 0.47% 43
2025
Q2
$631M Sell
7,610,581
-2,490,899
-25% -$199M 0.49% 38
2025
Q1
$819M Sell
10,101,480
-1,783,010
-15% -$159M 0.63% 29
2024
Q4
$1.07B Buy
11,884,490
+8,873,467
+295% +$860M 0.83% 21
2024
Q3
$297M Sell
3,011,023
-2,271,280
-43% -$223M 0.29% 93
2024
Q2
$490M Buy
5,282,303
+1,629,380
+45% +$146M 0.53% 48
2024
Q1
$347M Buy
3,652,923
+2,951,022
+420% +$274M 0.43% 65
2023
Q4
$62.7M Sell
701,901
-2,214,536
-76% -$164M 0.11% 297
2023
Q3
$213M Buy
2,916,437
+201,302
+7% +$16.1M 0.47% 62
2023
Q2
$226M Buy
2,715,135
+1,641,600
+153% +$137M 0.45% 57
2023
Q1
$81.8M Buy
1,073,535
+583,998
+119% +$48.5M 0.18% 176
2022
Q4
$40.6M Sell
489,537
-1,594,745
-77% -$129M 0.1% 386
2022
Q3
$165M Sell
2,084,282
-1,691,513
-45% -$143M 0.42% 64
2022
Q2
$280M Sell
3,775,795
-610,217
-14% -$45.8M 0.63% 35
2022
Q1
$394M Buy
4,386,012
+3,254,587
+288% +$301M 0.78% 21
2021
Q4
$127M Sell
1,131,425
-4,082,782
-78% -$492M 0.3% 110
2021
Q3
$655M Sell
5,214,207
-590,385
-10% -$76M 1.55% 8
2021
Q2
$786M Sell
5,804,592
-886,020
-13% -$116M 1.52% 6
2021
Q1
$908M Buy
6,690,612
+6,432,956
+2,497% +$963M 1.98% 8
2020
Q4
$36.3M Sell
257,656
-4,453,999
-95% -$570M 0.14% 301
2020
Q3
$525M Sell
4,711,655
-3,079,589
-40% -$345M 1.1% 17
2020
Q2
$872M Sell
7,791,244
-820,053
-10% -$80.8M 2.22% 6
2020
Q1
$667M Buy
8,611,297
+7,511,297
+683% +$665M 2.03% 7
2019
Q4
$105M Sell
1,100,000
-10,511,013
-91% -$909M 0.4% 108
2019
Q3
$885M Buy
11,611,013
+2,529,967
+28% +$210M 2.71% 3
2019
Q2
$796M Buy
9,081,046
+3,056,439
+51% +$261M 2.66% 3
2019
Q1
$545M Buy
6,024,607
+3,653,555
+154% +$311M 1.95% 8
2018
Q4
$170M Sell
2,371,052
-1,155,040
-33% -$93.1M 0.86% 40
2018
Q3
$338M Buy
3,526,092
+416,199
+13% +$40.4M 0.78% 25
2018
Q2
$296M Buy
3,109,893
+114,787
+4% +$10.5M 0.81% 30
2018
Q1
$263M Sell
2,995,106
-532,522
-15% -$48.6M 0.82% 31
2017
Q4
$299M Sell
3,527,628
-485,732
-12% -$40.7M 1.2% 27
2017
Q3
$347M Sell
4,013,360
-1,401,640
-26% -$112M 0.88% 13
2017
Q2
$418M Buy
5,415,000
+1,599,460
+42% +$113M 1.32% 7
2017
Q1
$265M Buy
3,815,540
+1,608,170
+73% +$108M 0.73% 22
2016
Q4
$131M Sell
2,207,370
-978,980
-31% -$60.4M 0.66% 28
2016
Q3
$211M Sell
3,186,350
-747,070
-19% -$46.2M 0.87% 19
2016
Q2
$213M Buy
3,933,420
+1,599,830
+69% +$87.7M 0.96% 12
2016
Q1
$121M Sell
2,333,590
-632,750
-21% -$32.9M 0.51% 37
2015
Q4
$208M Buy
2,966,340
+858,080
+41% +$58.5M 0.51% 36
2015
Q3
$131M Sell
2,108,260
-1,650,080
-44% -$130M 0.33% 42
2015
Q2
$316M Buy
3,758,340
+2,249,811
+149% +$175M 0.88% 16
2015
Q1
$113M Buy
1,508,529
+1,499,880
+17,342% +$105M 0.31% 52
2014
Q4
$538K Buy
8,649
+117
+1% +$6.67K ﹤0.01% 1106
2014
Q3
$444K Buy
8,532
+144
+2% +$7.34K ﹤0.01% 1575
2014
Q2
$431K Buy
+8,388
New +$378K ﹤0.01% 1546

Other funds holding XBI